Andrew Dellinger

1.3k citations

27 papers · 935 indexed · h-index 12

Impact in

Hepatology top 5%
- Liver physiology and pathology
Epidemiology top 5%
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Pharmacology 9
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 3
Hepatology 7
- Liver Disease and Transplantation 4

Co-authors: Herbert Pang (10 shared papers)Allison E. Ashley‐Koch (5 shared papers)Michael A. Hauser (8 shared papers)Anna Mae Diehl (5 shared papers)Hans L. Tillmann (6 shared papers)Cynthia A. Moylan (6 shared papers)Manal F. Abdelmalek (6 shared papers)Ayako Suzuki (5 shared papers)
Journals: Gastroenterology (5 papers)Journal of Hepatology (3 papers)The American Journal of Gastroenterology (3 papers)Cancer Medicine (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
Partner nations: United States United Kingdom Hong Kong

In The Last Decade

Andrew Dellinger

26 papers receiving 925 citations

Peers

Countries citing papers authored by Andrew Dellinger

Since Specialization

Citations

This map shows the geographic impact of Andrew Dellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dellinger more than expected).

Fields of papers citing papers by Andrew Dellinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Dellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dellinger. The network helps show where Andrew Dellinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Dellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Dellinger Line = papers co-authored together Andrew Dellinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease Gastroenterology ·Susan K. Murphy, Hyuna Yang, Cynthia A. Moylan, Herbert Pang, Andrew Dellinger, Manal F. Abdelmalek, Melanie E. Garrett, Allison E. Ashley‐Koch, Ayako Suzuki, Hans L. Tillmann, Michael A. Hauser, Anna Mae Diehl	2013	298
2	Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease Hepatology ·Cynthia A. Moylan, Herbert Pang, Andrew Dellinger, Ayako Suzuki, Melanie E. Garrett, Cynthia D. Guy, Susan K. Murphy, Allison E. Ashley‐Koch, Steve S. Choi, Gregory A. Michelotti, Daniel Hampton, Yuping Chen, Hans L. Tillmann, Michael A. Hauser, Manal F. Abdelmalek, Anna Mae Diehl	2013	234
3	Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays Nucleic Acids Research ·Andrew Dellinger, Seang‐Mei Saw, Liang Kee Goh, Mark Seielstad, Terri L. Young, Yi‐Ju Li	2010	79
4	Gene Expression Profile in Human Trabecular Meshwork From Patients With Primary Open-Angle Glaucoma Investigative Ophthalmology & Visual Science ·Yutao Liu, R. Rand Allingham, Xuejun Qin, David Layfield, Andrew Dellinger, Jason Gibson, Joshua Wheeler, Allison E. Ashley‐Koch, W. Daniel Stamer, Michael A. Hauser	2013	58
5	Human Leukocyte Antigen B14:01 and B35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury Hepatology ·Yi‐Ju Li, Elizabeth J. Phillips, Andrew Dellinger, Paola Nicoletti, Ryan J. Schutte, Danmeng Li, David A. Ostrov, Robert J. Fontana, Paul B. Watkins, Andrew Stolz, Ann K. Daly, Guruprasad P. Aithal, Huiman X. Barnhart, Naga Chalasani, (unknown)	2020	53
6	Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors Cancer Chemotherapy and Pharmacology ·John H. Strickler, Alexander Starodub, Jingquan Jia, Kellen L. Meadows, Andrew B. Nixon, Andrew Dellinger, Michael A. Morse, Hope E. Uronis, P. Kelly Marcom, S. Yousuf Zafar, Sherri Haley, Herbert I. Hurwitz	2012	36
7	Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury Journal of Hepatology ·Naga Chalasani, Yi‐Ju Li, Andrew Dellinger, Victor J. Navarro, Herbert L. Bonkovsky, Robert J. Fontana, Jiezhun Gu, Huiman X. Barnhart, Elizabeth Phillips, Craig Lammert, Tae‐Hwi Schwantes‐An, Paola Nicoletti, David E. Kleiner, Jay H. Hoofnagle	2022	25
8	Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate Gastroenterology ·Paola Nicoletti, Andrew Dellinger, Yi‐Ju Li, Huiman X. Barnhart, Naga Chalasani, Robert J. Fontana, Joseph A. Odin, José Serrano, Andrew Stolz, Amy S. Etheridge, Federico Innocenti, Olivier Govaere, Jane I. Grove, Camilla Stephens, Guruprasad P. Aithal, Raúl J. Andrade, Einar S. Björnsson, Ann K. Daly, M. Isabel Lucena, Paul B. Watkins	2022	25
9	Modulation of circulating protein biomarkers following TRC105 (anti‐endoglin antibody) treatment in patients with advanced cancer Cancer Medicine ·Yingmiao Liu, Mark D. Starr, John C. Brady, Andrew Dellinger, Herbert Pang, Bonne J. Adams, Charles P. Theuer, Nam Y. Lee, Herbert I. Hurwitz, Andrew B. Nixon	2014	23
10	A phase I study ofABT‐510 plus bevacizumab in advanced solid tumors Cancer Medicine ·Hope E. Uronis, Stephanie M. Cushman, Johanna C. Bendell, Gerard C. Blobe, Michael A. Morse, Andrew B. Nixon, Andrew Dellinger, Mark D. Starr, Haiyan Li, Kellen L. Meadows, Jon P. Gockerman, Herbert Pang, Herbert I. Hurwitz	2013	21
11	Transcriptome profiling of genes involved in neural tube closure during human embryonic development using long serial analysis of gene expression (long‐SAGE) Birth Defects Research Part A Clinical and Molecular Teratology ·Deidre R. Krupp, Pu‐Ting Xu, Sophie Thomas, Andrew Dellinger, Heather Etchevers, Michel Vekemans, John R. Gilbert, Marcy C. Speer, Allison E. Ashley‐Koch, Simon G. Gregory	2012	17
12	Serial analysis of gene expression (SAGE) in normal human trabecular meshwork. PubMed ·Yutao Liu, Drew Munro, David Layfield, Andrew Dellinger, Jeffrey W. Walter, Katherine Peterson, Catherine Bowes Rickman, R. Rand Allingham, Michael A. Hauser	2011	16
13	A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·Hope E. Uronis, Jingquan Jia, Johanna C. Bendell, Leigh A. Howard, Neal A. Ready, Paula H. Lee, Mark D. Starr, Andrew Dellinger, Herbert Pang, Andrew B. Nixon, Herbert I. Hurwitz	2014	8
14	Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data Cancer Informatics ·Andrew Dellinger, Andrew B. Nixon, Herbert Pang	2014	7
15	Principal-component-based multivariate regression for genetic association studies of metabolic syndrome components BMC Genetics ·Hao Mei, Wei Chen, Andrew Dellinger, Jiang He, Meng Wang, Canddy L. Yau, Sathanur R. Srinivasan, Gerald S. Berenson	2010	6
16	Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations Liver International ·Herbert L. Bonkovsky, Marwan Ghabril, Paola Nicoletti, Andrew Dellinger, Robert J. Fontana, Huiman X. Barnhart, Jiezhun Gu, Ann K. Daly, Guruprasad P. Aithal, Elizabeth J. Phillips, David E. Kleiner, (unknown)	2024	5
17	HLA-B53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans The American Journal of Gastroenterology* ·Paola Nicoletti, Andrew Dellinger, Yi‐Ju Li, Huiman X. Barnhart, Elizabeth J. Phillips, Naga Chalasani, (unknown)	2023	5
18	Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing Clinical Cancer Research ·Jingquan Jia, Andrew Dellinger, Eric S. Weiss, Anuradha Bulusu, Christel Rushing, Haiyan Li, Leigh A. Howard, Neal Kaplan, Herbert Pang, Herbert I. Hurwitz, Andrew B. Nixon	2015	4
19	When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network The American Journal of Gastroenterology ·A. Sidney Barritt, Huiman Barnhart, Jiezhun Gu, Andrew Dellinger, Sean Rudnick, Herbert L. Bonkovsky, (unknown)	2023	4
20	Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network The American Journal of Gastroenterology ·Jawad Ahmad, Andrew Dellinger, Paola Nicoletti, Huiman X. Barnhart, Marwan Ghabril, Robert J. Fontana, Victor J. Navarro, Gina Choi, Paul H. Hayashi, Jiezhun Gu, David E. Kleiner, (unknown)	2025	2

About Andrew Dellinger

Andrew Dellinger is a scholar working on Pharmacology, Hepatology, Endocrinology, Diabetes and Metabolism, Computer Graphics and Computer-Aided Design and Epidemiology, having authored 27 papers that have together received 935 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Diet, Metabolism, and Disease (5 papers), Liver Disease and Transplantation (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Peptidase Inhibition and Analysis (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Hepatology (168 citations), Epidemiology (490 citations), Pharmacology (98 citations), Endocrinology, Diabetes and Metabolism (165 citations) and Cell Biology (130 citations). Andrew Dellinger has collaborated with scholars based in United States, United Kingdom and Hong Kong. Frequent co-authors include Herbert Pang, Allison E. Ashley‐Koch, Michael A. Hauser, Anna Mae Diehl, Hans L. Tillmann, Cynthia A. Moylan, Manal F. Abdelmalek, Ayako Suzuki, Melanie E. Garrett and Susan K. Murphy. Their work appears in journals such as Gastroenterology, Journal of Hepatology, The American Journal of Gastroenterology, Cancer Medicine and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact